Details of Drug

Drug General Information (ID: D1201)
Drug Name	Oxtriphylline
Drug Type	Small molecule
Drug Synonymous	Choledyl; Cholegyl; Cholinophyllin; Cholinophylline; Filoral; Oxtrimethylline; Sabidal; Soliphylline; Teofilcolina; Teokolin; Theoxylline; Choline theophylline salt; Cholini theophyllinas; Colina teofillinato; Colina teofillinato [DCIT]; Oxtriphylline [USAN]; Oxtriphylline pediatric; Teofilinato de colina; Theophyllinate de choline; Theophylline cholinate; Theophylline salt of choline; Choledyl SA 400; Zy 15061; Choledyl (TN); Cholini theophyllinas [INN-Latin]; Teofilinato de colina [INN-Spanish]; Theophyllinate de choline[INN-French]; Choline salt with theophylline (1:1); Theophylline, compd. with choline; Choline, compd. with theophylline (1:1); Choline, hydroxide, compd. with theophylline (1:1); Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 3,7-dihydro-1,3-dimethylpurine-2,6-dione; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1); (2-Hydroxyethyl)trimethylammonium compound with theophylline; 1,3-dimethyl-7H-purine-2,6-dione; 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, ion(1-), 2-hydroxy-N,N,N-trimethylethanaminium Click to Show/Hide
Disease Class	MD12: Cough
Therapeutic Class	Bronchodilators
Structure
Structure	3D Structure		2D Structure
Formula	C12H21N5O3
InChI	1S/C7H8N4O2.C5H14NO/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;1-6(2,3)4-5-7/h3,12H,1-2H3;7H,4-5H2,1-3H3/q;+1/p-1
InChIKey	SOELXOBIIIBLRJ-UHFFFAOYSA-M
Canonical SMILES	CN1C(=C2C(=NC=N2)N(C1=O)C)[O-].C[N+](C)(C)CCO
External Link
	Pubchem ID	656652
	CAS Number	4499-40-5
	TTD ID	D0B0SH
	INTEDE ID	DR1217

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM003 Affected organization distribution AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM003 Complex formation BM004 Adsorption BM009 Altered absorption (Unspecific) BM013 Competitive binding of plasma proteins BM016 Altered formation of CYP450 enzymes BM017 CYP450 enzyme inhibition BM018 Non-CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM025 Decreased metabolism (Unspecific) BM026 Increased metabolism (Unspecific) BM042 Additive hypotensive effects BM065 Increased risk of hypokalemia BM069 Increased risk of lowers seizure threshold BM087 Antagonize the effect of antiepileptic agents BM090 Antagonize the effect of bronchodilators BM095 Antagonize the effect of neuromuscular blocking agents BM107 Attenuated pharmacological effects (Unspecific) BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Oxtriphylline
Affected gastrointestinal absorption
	Complex formation					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0381		Colesevelam	C31H67Cl3N4O	160051	Moderate		Inter Info	[8], [167]
	Adsorption					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0021		Activated charcoal	C	5462310	Moderate		Inter Info	[206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230]
	Altered absorption (Unspecific)					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0640		Felodipine	C18H19Cl2NO4	3333	Minor		Inter Info	[273], [5]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Minor		Inter Info	[274], [275]
Affected organization distribution
	Competitive binding of plasma proteins					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1094		Mycophenolate mofetil	C23H31NO7	5281078	Minor		Inter Info	[276]
D1095		Mycophenolic acid	C17H20O6	446541	Minor		Inter Info	[276]
Affected intra/extra-hepatic metabolism
	Altered formation of CYP450 enzymes					Drug Num: 18
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0023		Adalimumab	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0032		Alefacept	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0085		Anakinra	C20H23N5O7S2	146171046	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0614		Etanercept	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0802		Infliximab	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0246		Canakinumab	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0304		Certolizumab pegol	NA	NA	Moderate		Inter Info	[85], [87], [92]
D0564		Emapalumab	NA	NA	Moderate		Inter Info	[85], [87], [92]
D0736		Golimumab	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0747		Guselkumab	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0875		Ixekizumab	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1403		Rilonacept	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1447		Sarilumab	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1448		Satralizumab	NA	NA	Moderate		Inter Info	[85], [87], [92]
D1454		Secukinumab	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1467		Siltuximab	NA	NA	Moderate		Inter Info	[85], [87], [92]
D1599		Tocilizumab	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1671		Ustekinumab	NA	NA	Moderate		Inter Info	[51], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
	CYP450 enzyme inhibition					Drug Num: 36
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0341		Ciprofloxacin	C17H18FN3O3	2764	Major		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Major		Inter Info	[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61]
D1054		Mexiletine	C11H17NO	4178	Major		Inter Info	[64], [65], [66], [67], [68], [69], [70], [71], [5]
D0432		Deferasirox	C21H15N3O4	214348	Major		Inter Info	[72]
D0066		Amiodarone	C25H29I2NO3	2157	Moderate		Inter Info	[99]
D0139		Azithromycin	C38H72N2O12	447043	Moderate		Inter Info	[103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [39], [129], [46], [130], [131], [132]
D0337		Cimetidine	C10H16N6S	2756	Moderate		Inter Info	[138], [139], [140], [141], [142], [143], [144], [145], [53], [146], [147], [148], [149], [150], [151], [152], [153], [32], [154], [155], [156], [157], [158], [159], [160], [5], [161], [162], [163]
D0349		Clarithromycin	C38H69NO13	84029	Moderate		Inter Info	[103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [39], [129], [46], [130], [131], [132]
D0441		Demeclocycline	C21H21ClN2O8	54680690	Moderate		Inter Info	[168], [169], [46]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[170], [171], [172], [154], [173], [174], [5]
D0509		Disulfiram	C10H20N2S4	3117	Moderate		Inter Info	[175], [5]
D0530		Doxycycline	C22H24N2O8	54671203	Moderate		Inter Info	[168], [169], [46]
D0597		Erythromycin	C37H67NO13	12560	Moderate		Inter Info	[103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [39], [129], [46], [130], [131], [132]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[138], [139], [140], [141], [142], [143], [144], [145], [53], [146], [147], [148], [149], [150], [151], [152], [153], [32], [154], [155], [156], [157], [158], [159], [160], [5], [161], [162], [163]
D0822		Interferon alfa-2b	C16H17Cl3I2N3NaO5S	71306834	Moderate		Inter Info	[78], [51], [181], [182], [183], [184], [185], [5], [186]
D0825		Interferon alfa-n3	NA	NA	Moderate		Inter Info	[78], [51], [181], [182], [183], [184], [185], [5], [186]
D0823		Interferon alfacon-1	NA	NA	Moderate		Inter Info	[181], [184], [185]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[78], [51], [181], [182], [183], [184], [185], [5], [186]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[78], [51], [181], [182], [183], [184], [185], [5], [186]
D0828		Interferon gamma-1b	NA	NA	Moderate		Inter Info	[78], [51], [181], [182], [183], [184], [185], [5], [186]
D0858		Isoniazid	C6H7N3O	3767	Moderate		Inter Info	[187], [188], [189], [46]
D1070		Minocycline	C23H27N3O7	54675783	Moderate		Inter Info	[168], [169], [46]
D1151		Nizatidine	C12H21N5O2S2	3033637	Moderate		Inter Info	[138], [139], [140], [141], [142], [143], [144], [145], [53], [146], [147], [148], [149], [150], [151], [152], [153], [32], [154], [155], [156], [157], [158], [159], [160], [5], [161], [162], [163]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[196], [29], [48]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[197], [198], [199], [196], [29], [200], [201], [202], [203], [204], [36], [205], [41], [46], [48], [49]
D0191		Blinatumomab	NA	NA	Moderate		Inter Info	[233]
D1050		Metreleptin	NA	NA	Moderate		Inter Info	[246]
D1160		Obeticholic acid	C26H44O4	447715	Moderate		Inter Info	[247]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[78], [51], [181], [182], [183], [184], [185], [5], [186]
D1505		Stiripentol	C14H18O3	5311454	Moderate		Inter Info	[253]
D1237		Peginterferon alfa-2a	NA	NA	Moderate		Inter Info	[78], [51], [181], [182], [183], [184], [185], [5], [186]
D1238		Peginterferon alfa-2b	NA	NA	Moderate		Inter Info	[78], [51], [181], [182], [183], [184], [185], [5], [186]
D1381		Ranitidine	C13H22N4O3S	3001055	Moderate		Inter Info	[138], [139], [140], [141], [142], [143], [144], [145], [53], [146], [147], [148], [149], [150], [151], [152], [153], [32], [154], [155], [156], [157], [158], [159], [160], [5], [161], [162], [163]
D1564		Tetracycline	C22H24N2O8	54675776	Moderate		Inter Info	[168], [169], [46]
D1690		Verapamil	C27H38N2O4	2520	Moderate		Inter Info	[170], [261], [262], [263], [264], [265], [266], [5]
D1721		Zileuton	C11H12N2O2S	60490	Moderate		Inter Info	[267], [268], [269]
	Non-CYP450 enzyme inhibition					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0637		Febuxostat	C16H16N2O3S	134018	Moderate		Inter Info	[236]
	CYP450 enzyme induction					Drug Num: 17
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0224		Butabarbital	C10H16N2O3	2479	Moderate		Inter Info	[133], [134], [135], [46]
D0225		Butalbital	C11H16N2O3	2481	Moderate		Inter Info	[133], [134], [46]
D0255		Carbamazepine	C15H12N2O	2554	Moderate		Inter Info	[136], [137], [46]
D0621		Ethotoin	C11H12N2O2	3292	Moderate		Inter Info	[179], [180], [46]
D1003		Mephenytoin	C12H14N2O2	4060	Moderate		Inter Info	[179], [180], [46]
D1040		Methylphenobarbital	C13H14N2O3	8271	Moderate		Inter Info	[133], [134], [46]
D0071		Amobarbital	C11H18N2O3	2164	Moderate		Inter Info	[133], [134], [46]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[78], [51], [234], [235]
D0697		Fosphenytoin	C16H15N2O6P	56339	Moderate		Inter Info	[237], [179], [180], [46]
D1502		St. John's Wort	NA	NA	Moderate		Inter Info	[250], [251], [252]
D1248		Pentobarbital	C11H18N2O3	4737	Moderate		Inter Info	[133], [134], [135], [46]
D1265		Phenobarbital	C12H12N2O3	4763	Moderate		Inter Info	[133], [134], [135], [46]
D1283		Phenytoin	C15H12N2O2	1775	Moderate		Inter Info	[237], [179], [180], [46]
D1340		Primidone	C12H14N2O2	4909	Moderate		Inter Info	[133], [134], [135], [46]
D1400		Rifampicin	C43H58N4O12	135398735	Moderate		Inter Info	[187], [254], [255]
D1415		Ritonavir	C37H48N6O5S2	392622	Moderate		Inter Info	[256], [257]
D1453		Secobarbital	C12H18N2O3	5193	Moderate		Inter Info	[133], [134], [46]
	Decreased metabolism (Unspecific)					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0606		Estradiol	C18H24O2	5757	Moderate		Inter Info	[176], [177], [178]
D0619		Ethinylestradiol	C20H24O2	5991	Moderate		Inter Info	[176], [177], [178]
D0626		Etonogestrel	C22H28O2	6917715	Moderate		Inter Info	[176], [177], [178]
D0922		Levonorgestrel	C21H28O2	13109	Moderate		Inter Info	[176], [177], [178]
D1154		Norethisterone	C20H26O2	6230	Moderate		Inter Info	[176], [177], [178]
D0536		Drospirenone	C24H30O3	68873	Moderate		Inter Info	[176], [177], [178]
D1571		Thiabendazole	C10H7N3S	5430	Moderate		Inter Info	[258], [259], [260]
	Increased metabolism (Unspecific)					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0925		Levothyroxine	C15H11I4NO4	5819	Moderate		Inter Info	[190], [191], [192]
D0934		Liothyronine	C15H12I3NO4	5920	Moderate		Inter Info	[190], [191], [192]
D0935		Liotrix	C30H21I7N2Na2O8	71371	Moderate		Inter Info	[190], [191], [192]
D1577		Thyroid, porcine	NA	NA	Moderate		Inter Info	[190], [191], [192]
Pharmacodynamic additive effects
	Additive hypotensive effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1408		Riociguat	C20H19FN8O2	11304743	Major		Inter Info	[78], [51], [79]
	Increased risk of hypokalemia					Drug Num: 12
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[100], [101], [102]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[100], [101], [102]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[100], [101], [102]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[100], [101], [102]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[100], [101], [102]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[100], [101], [102]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[100], [101], [102]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[100], [101], [102]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[100], [101], [102]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[100], [101], [102]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[100], [101], [102]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[100], [101], [102]
	Increased risk of lowers seizure threshold					Drug Num: 11
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0220		Bupropion	C13H18ClNO	444	Major		Inter Info	[6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20]
D0833		Iohexol	C19H26I3N3O9	3730	Major		Inter Info	[73], [74], [75], [76], [77]
D0834		Iopamidol	C17H22I3N3O8	65492	Major		Inter Info	[73], [74], [75], [76], [77]
D1616		Tramadol	C16H25NO2	33741	Major		Inter Info	[80], [19], [18], [81]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[78], [51]
D0932		Lindane	C6H6Cl6	727	Moderate		Inter Info	[193], [194], [195]
D0054		Amifampridine	C5H7N3	5918	Moderate		Inter Info	[231], [232]
D0722		Ginkgo biloba	NA	NA	Moderate		Inter Info	[238], [239], [240], [241], [242], [243], [244], [245]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[248], [249], [51]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[248], [249], [51]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[248], [249], [51]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0751		Halothane	C2HBrClF3	3562	Major		Inter Info	[62], [63]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antiepileptic agents					Drug Num: 15
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0045		Alprazolam	C17H13ClN4	2118	Minor		Inter Info	[270], [271], [272]
D0317		Chlordiazepoxide	C16H14ClN3O	2712	Minor		Inter Info	[270], [271], [272]
D0356		Clobazam	C16H13ClN2O2	2789	Minor		Inter Info	[270], [271], [272]
D0362		Clonazepam	C15H10ClN3O3	2802	Minor		Inter Info	[270], [271], [272]
D0365		Clorazepic acid	C16H11ClN2O3	2809	Minor		Inter Info	[270], [271], [272]
D0473		Diazepam	C16H13ClN2O	3016	Minor		Inter Info	[270], [271], [272]
D0604		Estazolam	C16H11ClN4	3261	Minor		Inter Info	[270], [271], [272]
D0679		Flurazepam	C21H23ClFN3O	3393	Minor		Inter Info	[270], [271], [272]
D0951		Lorazepam	C15H10Cl2N2O2	3958	Minor		Inter Info	[270], [271], [272]
D1060		Midazolam	C18H13ClFN3	4192	Minor		Inter Info	[270], [271], [272]
D1197		Oxazepam	C15H11ClN2O2	4616	Minor		Inter Info	[270], [271], [272]
D1367		Quazepam	C17H11ClF4N2S	4999	Minor		Inter Info	[270], [271], [272]
D1391		Remimazolam	C21H19BrN4O2	9867812	Minor		Inter Info	[270], [271], [272]
D1547		Temazepam	C16H13ClN2O2	5391	Minor		Inter Info	[270], [271], [272]
D1632		Triazolam	C17H12Cl2N4	5556	Minor		Inter Info	[270], [271], [272]
	Antagonize the effect of bronchodilators					Drug Num: 19
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0010		Acebutolol	C18H28N2O4	1978	Major		Inter Info	[1], [2], [3], [4], [5]
D0117		Atenolol	C14H22N2O3	2249	Major		Inter Info	[3], [4], [5]
D0173		Betaxolol	C18H29NO3	2369	Major		Inter Info	[3], [4], [5]
D0174		Betaxolol (ophthalmic)	C18H29NO3	2369	Major		Inter Info	[3], [4], [5]
D0188		Bisoprolol	C18H31NO4	2405	Major		Inter Info	[3], [4], [5]
D0266		Carteolol (ophthalmic)	C16H24N2O3	2583	Major		Inter Info	[3], [4], [5]
D0267		Carvedilol	C24H26N2O4	2585	Major		Inter Info	[3], [4], [5]
D0602		Esmolol	C16H25NO4	59768	Major		Inter Info	[3], [4], [5]
D0884		Labetalol	C19H24N2O3	3869	Major		Inter Info	[3], [4], [5]
D0915		Levobunolol (ophthalmic)	C17H25NO3	39468	Major		Inter Info	[3], [4], [5]
D1045		Metipranolol (ophthalmic)	C17H27NO4	31477	Major		Inter Info	[3], [4], [5]
D1049		Metoprolol	C15H25NO3	4171	Major		Inter Info	[3], [4], [5]
D1098		Nadolol	C17H27NO4	39147	Major		Inter Info	[3], [4], [5]
D1114		Nebivolol	C22H25F2NO4	71301	Major		Inter Info	[3], [4], [5]
D1293		Pindolol	C14H20N2O2	4828	Major		Inter Info	[3], [4], [5]
D1357		Propranolol	C16H21NO2	4946	Major		Inter Info	[3], [4], [5]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[3], [4], [5]
D1585		Timolol	C13H24N4O3S	33624	Major		Inter Info	[3], [4], [5]
D1586		Timolol (ophthalmic)	C13H24N4O3S	33624	Major		Inter Info	[3], [4], [5]
	Antagonize the effect of neuromuscular blocking agents					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0343		Cisatracurium	C53H72N2O12+2	62887	Moderate		Inter Info	[164], [165], [166]
D0522		Doxacurium	C56H78N2O16+2	60169	Moderate		Inter Info	[164], [165], [166]
D1080		Mivacurium	C58H80N2O14+2	5281042	Moderate		Inter Info	[164], [165], [166]
D0122		Atracurium	C53H72N2O12+2	47319	Moderate		Inter Info	[164], [165], [166]
D1219		Pancuronium	C35H60N2O4+2	441289	Moderate		Inter Info	[164], [165], [166]
D1684		Vecuronium	C34H57N2O4+	39765	Moderate		Inter Info	[164], [165], [166]
D1420		Rocuronium	C32H53N2O4+	441290	Moderate		Inter Info	[164], [165], [166]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0025		Adenosine	C10H13N5O4	60961	Moderate		Inter Info	[96], [97], [98]
D0506		Dipyridamole	C24H40N8O4	3108	Moderate		Inter Info	[96], [97], [98]
D1877		Regadenoson	C15H18N8O5	219024	Moderate		Inter Info	[96], [97], [98]
D1356		Propofol	C12H18O	4943	Minor		Inter Info	[277], [278], [279]

References
1	Conrad KA, Nyman DW "Effects of metoprolol and propranolol on theophylline elimination." Clin Pharmacol Ther 28 (1980): 463-7. [PMID: 7408406]
2	Horvath JS, Woolcock AJ, Tiller DJ, Donnelly P, Armstrong J, Caterson R "A comparison of metoprolol and propranolol on blood pressure and respiratory function in patients with hypertension." Aust N Z J Med 8 (1978): 1-6.
3	Lombardi TP, Bertino JS, Goldberg A, Middleton E, Slaughter RL "The effects of a beta-2 selective adrenergic agonist and a beta- nonselective antagonist on theophylline clearance." J Clin Pharmacol 27 (1987): 523-9. [PMID: 2888791]
4	Mue S, Sasaki T, Shibahara S, et alT "Influence of metoprolol on hemodynamics and respiratory function in asthmatic patients." Int J Clin Pharmacol Biopharm 17 (1979): 346-50. [PMID: 489201]
5	Upton RA "Pharmacokinetic interactions between theophylline and other medication (Part II)." Clin Pharmacokinet 20 (1991): 135-50. [PMID: 1709398]
6	Product Information. Wellbutrin XL (buPROPion). GlaxoSmithKline, Philadelphia, PA.
7	Sheehan DV, Welch JB, Fishman SM "A case of bupropion-induced seizure." J Nerv Ment Dis 174 (1986): 496-8. [PMID: 3090199]
8	Canadian Pharmacists Association.
9	Product Information. Wellbutrin (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
10	Gittelman DK, Kirby MG "A seizure following bupropion overdose." J Clin Psychiatry 54 (1993): 162. [PMID: 8486598]
11	Product Information. Wellbutrin SR (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
12	James WA, Lippmann S "Bupropion: overview and prescribing guidelines in depression." South Med J 84 (1991): 222-4. [PMID: 1899294]
13	Masco HL, Kiev A, Holloman LC, Batey SR, Johnston JA, Lineberry CG "Safety and efficacy of bupropion and nortriptyline in outpatients with depression." Curr Ther Res Clin Exp 55 (1994): 851-63.
14	Dufresne RL, Weber SS, Becker RE "Bupropion hydrochloride." Drug Intell Clin Pharm 18 (1984): 957-64. [PMID: 6439541]
15	Product Information. Zyban (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
16	Storrow AB "Bupropion overdose and seizure." Am J Emerg Med 12 (1994): 183-4. [PMID: 8161393]
17	Johnston JA, Lineberry CG, Ascher JA, et al. "A 102-center prospective study of seizure in association with bupropion." J Clin Psychiatry 52 (1991): 450-6. [PMID: 1744061]
18	Rosenstein DL, Nelson JC, Jacobs SC "Seizures associated with antidepressants: a review." J Clin Psychiatry 54 (1993): 289-99. [PMID: 8253696]
19	Pisani F, Spina E, Oteri G "Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice." Epilepsia 40(Suppl 10) (1999): S48-56. [PMID: 10609604]
20	Product Information. Aplenzin (buPROPion). sanofi-aventis , Bridgewater, NJ.
21	Bachmann KA, Schwartz JI, Jauregui L "Predicting the ciprofloxacin-theophylline interaction from single plasma theophylline measurements." Br J Clin Pharmacol 26 (1988): 191-4. [PMID: 3207556]
22	Bader MB "Role of ciprofloxacin in fatal seizures." Chest 101 (1992): 883-4. [PMID: 1541177]
23	Batty KT, Davis TM, Ilett KF, Dusci LJ, Langton SR "The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects." Br J Clin Pharmacol 39 (1995): 305-11. [PMID: 7619673]
24	Bem JL, Mann RD "Danger of interaction between ciprofloxacin and theophylline." Br Med J (Clin Res Ed) 296 (1988): 1131. [PMID: 3132238]
25	Borcherding SM, Stevens R, Nicholas RA, Corley CR, Self T "Quinolones: a practical review of clinical uses, dosing considerations, and drug interactions." J Fam Pract 42 (1996): 69-78. [PMID: 8537808]
26	Davis RL, Quenzer RW, Kelly HW, Powell JR "Effect of the addition of ciprofloxacin on theophylline pharmacokinetics in subjects inhibited by cimetidine." Ann Pharmacother 26 (1992): 11-3. [PMID: 1606331]
27	Duraski RM "Ciprofloxacin-induced theophylline toxicity." South Med J 81 (1988): 1206. [PMID: 3420462]
28	Edwards DJ, Bowles SK, Svensson CK, Rybak MJ "Inhibition of drug metabolism by quinolone antibiotics." Clin Pharmacokinet 15 (1988): 194-204. [PMID: 3052987]
29	Grasela TH, Dreis MW "An evaluation of the quinolone-theophylline interaction using the Food and Drug Administration spontaneous reporting system." Arch Intern Med 152 (1992): 617-21. [PMID: 1312320]
30	Holden R "Probable fatal interaction between ciprofloxacin and theophylline." Br Med J 297 (1988): 1339. [PMID: 3144397]
31	Karki SD, Bentley DW, Raghavan M "Seizure with ciprofloxacin and theophylline combined therapy." DICP 24 (1990): 595-6. [PMID: 2360338]
32	Loi CM, Parker BM, Cusack BJ, Vestal RE "Aging and drug interactions .3. individual and combined effects of cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers." J Pharmacol Exp Ther 280 (1997): 627-37. [PMID: 9023273]
33	Mizuki Y, Fujiwara I, Yamaguchi T "Pharmacokinetic interactions related to the chemical structures of fluoroquinolones." J Antimicrob Chemother 37 ( Suppl (1996): 41-55. [PMID: 8737124]
34	Polk RE "Drug-drug interactions with ciprofloxacin and other fluoroquinolones." Am J Med 87 (1989): s76-81. [PMID: 2686430]
35	Prince RA, Casabar E, Adair CG, et al "Effect of quinolone antimicrobials on theophylline pharmacokinetics." J Clin Pharmacol 29 (1989): 650-4. [PMID: 2760258]
36	Raoof S, Wollschlager C, Khan FA "Ciprofloxacin increases serum levels of theophylline." Am J Med 82 (1987): 115-8. [PMID: 3578320]
37	Richardson JP "Theophylline toxicity associated with the administration of ciprofloxacin in a nursing home patient." J Am Geriatr Soc 38 (1990): 236-8. [PMID: 2313005]
38	Robson RA, Begg EJ, Atkinson HC, et al "Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline." Br J Clin Pharmacol 29 (1990): 491-3. [PMID: 2328197]
39	Rockwood RP, Embardo LS "Theophylline, ciprofloxacin, erythromycin: a potentially harmful regimen." Ann Pharmacother 27 (1993): 651-2. [PMID: 8347920]
40	Schwartz J, Jauregui L, Lettieri J, Bachmann K "Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum." Antimicrob Agents Chemother 32 (1988): 75-7. [PMID: 3348614]
41	Segev S. Rehavi M, Rubinstein E "Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor." Antimicrob Agents Chemother 32 (1988): 1624-6. [PMID: 2855295]
42	Semel JD, Allen N "Seizures in patients simultaneously receiving theophylline and imipenem or ciprofloxacin or metronidazole." South Med J 84 (1991): 465-8. [PMID: 1901667]
43	Spivey JM, Laughlin PH, Goss TF, et al "Theophylline toxicity secondary to ciprofloxacin administration." Ann Emerg Med 20 (1991): 1131-4. [PMID: 1928889]
44	Takagi K, Hasegawa T, Ogura Y, et al "Comparative studies on interaction between theophylline and quinolones." J Asthma 25 (1988): 63-71. [PMID: 3182580]
45	Thomson AH, Thomson GD, Hepburn M, Whiting B "A clinically significant interaction between ciprofloxacin and theophylline." Eur J Clin Pharmacol 33 (1987): 435-6. [PMID: 3443151]
46	Upton RA "Pharmacokinetic interactions between theophylline and other medication (Part I)." Clin Pharmacokinet 20 (1991): 66-80. [PMID: 1674242]
47	Wijnands GJ, Vree TB, Janssen TJ, Guelen PJ "Drug-drug interactions affecting fluoroquinolones." Am J Med 87 (1989): s47-51. [PMID: 2603893]
48	Wijnands WJ, Vree TB "Interaction between the fluoroquinolones and the bronchodilator theophylline." J Antimicrob Chemother 22 (1988): 109-14. [PMID: 3053575]
49	Wijnands WJ, Vree TB, Baars AM, van Herwaarden CL "Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintneance treatment with theophylline." Drugs 34 (1987): 159-69. [PMID: 3481317]
50	Brosen K, Skjelbo E, Rasmussen BB, Poulsen HE, Loft S "Fluvoxamine is a potent inhibitor of cytochrome P4501A2." Biochem Pharmacol 45 (1993): 1211-4. [PMID: 8466541]
51	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
52	Devane CL, Markowitz JS, Hardesty SJ, Mundy S, Gill HS "Fluvoxamine-induced theophylline toxicity." Am J Psychiatry 154 (1997): 1317-8. [PMID: 9286199]
53	Hardman JG, Gilman AG, Limbird LE eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 9th ed." New York, NY: McGraw-Hill (1995):.
54	Nemeroff CB, Devane CL, Pollock BG "Newer antidepressants and the cytochrome p450 system." Am J Psychiatry 153 (1996): 311-20. [PMID: 8610817]
55	Orlando R, Padrini R, Perazzi M, De Martin S, Piccoli P, Palatini P "Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine." Clin Pharmacol Ther 79 (2006): 489-99. [PMID: 16678550]
56	Product Information. Luvox (fluvoxamine). Solvay Pharmaceuticals Inc, Marietta, GA.
57	Rasmussen BB, Jeppesen U, Gaist D, Brosen K "Griseofulvin and fluvoxamine interactions with the metabolism of theophylline." Ther Drug Monit 19 (1997): 56-62. [PMID: 9029748]
58	Rasmussen BB, Maenpaa J, Pelkonen O, et al "Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine." Br J Clin Pharmacol 39 (1995): 151-9. [PMID: 7742153]
59	Sperber AD "Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy." Drug Saf 6 (1991): 460-2. [PMID: 1793525]
60	van den Brekel AM, Harriington L "Toxic effects of theophylline caused by fluoxamine." CMAJ 151 (1994): 1289-90. [PMID: 7954177]
61	Yao C, Kunze KL, Kharasch ED, et al. "Fluvoxamine-theophylline interaction: Gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2." Clin Pharmacol Ther 70 (2001): 415-24. [PMID: 11719727]
62	Roizen MF, Stevens WC "Multiform ventricular tachycardia due to the interaction of aminophylline and halothane." Anesth Analg 57 (1978): 738-41.[PMID: 570000]
63	Richards W, Thompson J, Lewis G, et al "Cardiac arrest associated with halothane anesthesia in a patient receiving theophylline." Ann Allergy 61 (1988): 83-4.[PMID: 3400904]
64	Hurwitz A, Vacek JL, Botteron GW, et al "Mexiletine effects on theophylline disposition." Clin Pharmacol Ther 50 (1991): 299-307. [PMID: 1914365]
65	Katz A, Buskila D, Sukenik S "Oral mexiletine-theophylline interaction." Int J Cardiol 17 (1987): 227-8. [PMID: 3679607]
66	Kessler KM, Interian A, Cox M, et al "Proarrhythmia related to a kinetic and dynamic interaction of mexiletine and theophylline." Am Heart J 117 (1989): 964-6. [PMID: 2929410]
67	Loi CM, Wei X, Vestal RE "Inhibition of theophylline metabolism by mexiletine in young male and female nonsmokers." Clin Pharmacol Ther 49 (1991): 571-80. [PMID: 2029830]
68	Stanley R, Comer T, Taylor JL, Saliba D "Mexiletine-theophylline interaction." Am J Med 86 (1989): 733-4. [PMID: 2729333]
69	Stoysich AM, Mohiuddin SM, Destache CJ, et al "Influence of mexiletine on the pharmacokinetics of theophylline in healthy volunteers." J Clin Pharmacol 31 (1991): 354-7. [PMID: 2037708]
70	Ueno K, Miyai K, Kato M, et al "Mechanism of interaction between theophylline and mexiletine." DICP 25 (1991): 727-30. [PMID: 1949927]
71	Ueno K, Miyai K, Seki T, Kawaguchi Y "Interaction between theophylline and mexiletine." DICP 24 (1990): 471-2. [PMID: 1693023]
72	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
73	Product Information. Isovue-M-200 (iopamidol). Bracco Diagnostics Inc, Princeton, NJ.
74	Product Information. Amipaque (metrizamide) Nycomed Inc, Princeton, NJ.
75	Hindmarsh T, Grepe A, Widen L "Metrizamide-phenothiazine interaction: report of a case with seizures following myelography." Acta Radiol Diagn (Stockh) 16 (1975): 129-35. [PMID: 810000]
76	Product Information. Omnipaque 180 (iohexol). Amersham Health, Princeton, NJ.
77	Product Information. Osmovist 240 (iotrolan). Berlex Canada Inc, Lachine, QC.
78	Cerner Multum, Inc. "Australian Product Information.".
79	Product Information. Adempas (riociguat). Bayer Pharmaceutical Inc, West Haven, CT.
80	Product Information. Ultram (tramadol). McNeil Pharmaceutical, Raritan, NJ.
81	Gardiner JS, Blough D, Drinkard CR, et al. "Tramadol and seizures: a surveillance study in a managed care population." Pharmacotherapy 20 (2000): 1423-31. [PMID: 11130214]
82	Product Information. Actemra (tocilizumab). Genentech, South San Francisco, CA.
83	Product Information. Amevive (alefacept). Biogen, Cambridge, MA.
84	Product Information. Arcalyst (rilonacept). Regeneron Pharmaceuticals Inc, Tarrytown, NY.
85	Product Information. Cosentyx (secukinumab). Novartis Pharmaceuticals, East Hanover, NJ.
86	Product Information. Gamifant (emapalumab). Sobi Inc, Ardmore, PA.
87	Product Information. Ilaris (canakinumab). Novartis Pharmaceuticals, East Hanover, NJ.
88	Product Information. Ilumya (tildrakizumab). Merck & Company Inc, Whitehouse Station, NJ.
89	Product Information. Kevzara (sarilumab). sanofi-aventis, Bridgewater, NJ.
90	Product Information. Remicade (infliximab). Centocor Inc, Malvern, PA.
91	Product Information. Simponi (golimumab). Centocor Inc, Malvern, PA.
92	Product Information. Skyrizi (risankizumab). AbbVie US LLC, North Chicago, IL.
93	Product Information. Stelara (ustekinumab). Centocor Inc, Malvern, PA.
94	Product Information. Sylvant (siltuximab). Janssen Biotech, Inc., Horsham, PA, PA.
95	Product Information. Taltz Autoinjector (ixekizumab). Eli Lilly and Company, Indianapolis, IN.
96	Product Information. Persantine (dipyridamole). Boehringer-Ingelheim, Ridgefield, CT.
97	Ranhosky A, Kempthorne-Rawson J, the Intravenous Dipyridamole Thallium Imaging Study Group "The safety of intravenous dipyridamole thallium myocardial perfusion imaging." Circulation 81 (1990): 1205-9. [PMID: 2107985]
98	Smits P, Schouten J, Thien T "Respiratory stimulant effects of adenosine in man after caffeine and enprofylline." Br J Clin Pharmacol 24 (1987): 816-9. [PMID: 3440102]
99	Soto J, Sacristan JA, Arellano F, Hazas J "Possible theophylline-amiodarone interaction." DICP 24 (1990): 1115. [PMID: 2275239]
100	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
101	Amirav I, Amitai Y, Avital A, Godfrey S "Enhancement of theophylline clearance by intravenous albuterol." Chest 94 (1988): 444-5
102	Garty M, Paul-Keslin L, Ilfeld DN, et al "Increased theophylline clearance in asthmatic patients due to terbutaline." Eur J Clin Pharmacol 36 (1989): 25-8
103	Amsden GW "Erythromycin, clarithromycin, and azithromycin: are the differences real?" Clin Ther 18 (1996): 56-72. [PMID: 8851453]
104	Amsden GW "Macrolides versus azalides: a drug interaction update." Ann Pharmacother 29 (1995): 906-17. [PMID: 8547740]
105	Bachmann K, Jauregui L, Sides G, Sullivan TJ "Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin." J Clin Pharmacol 33 (1993): 861-5. [PMID: 8227485]
106	Bachmann K, Nunlee M, Martin M, et al "Changes in the steady-state pharmacokinetics of theophylline during treatment with dirithromycin." J Clin Pharmacol 30 (1990): 1001-5. [PMID: 2243147]
107	Branigan TA, Robbins RA, Cady WJ, et al "The effects of erythromycin on the absorption and disposition kinetics of theophylline." Eur J Clin Pharmacol 21 (1981): 115-20. [PMID: 7341279]
108	Descotes J, Andre P, Evreux JC "Pharmacokinetic drug interactions with macrolide antibiotics." J Antimicrob Chemother 15 (1985): 659-64. [PMID: 3897166]
109	Gillum JG, Israel DS, Scott RB, Climo MW, Polk RE "Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers." Antimicrob Agents Chemother 40 (1996): 1715-6. [PMID: 8807068]
110	Hildebrandt R, Moller H, Gundert-Remy U "Influence of theophylline on the renal clearance of erythromycin." Int J Clin Pharmacol Ther Toxicol 25 (1987): 601-4. [PMID: 3429062]
111	Iliopoulou A, Aldhous ME, Johnston A, Turner P "Pharmacokinetic interaction between theophylline and erythromycin." Br J Clin Pharmacol 14 (1982): 495-9. [PMID: 7138734]
112	Jonkman JH, Upton RA "Pharmacokinetic drug interactions with theophylline." Clin Pharmacokinet 9 (1984): 309-34. [PMID: 6147220]
113	Kamada AK, Hill MR, Brenner AM, Szefler SJ "Effect of low-dose troleandomycin on theophylline clearance: implications for therapeutic drug monitoring." Pharmacotherapy 12 (1992): 98-102. [PMID: 1570234]
114	Kozak PP, Cummins LH, Gillman SH "Administration of erythromycin to patients on theophylline." J Allergy Clin Immunol 60 (1977): 149-51. [PMID: 874213]
115	Ludden TM "Pharmacokinetic interactions of the macrolide antibiotics." Clin Pharmacokinet 10 (1985): 63-79. [PMID: 3882305]
116	Maddux MS, Leeds NH, Organek HW, Hasegawa GR, Bauman JL "The effect of erythromycin on theophylline pharmacokinetics at steady state." Chest 81 (1982): 563-5. [PMID: 7042226]
117	May DC, Jarboe CH, Ellenburg DT, et al "The effects of erythromycin on theophylline elimination in normal males." J Clin Pharmacol 22 (1982): 125-30. [PMID: 7068935]
118	Nahata M "Drug interactions with azithromycin and the macrolides: an overview." J Antimicrob Chemother 37 Suppl C (1996): 133-42. [PMID: 8818854]
119	Parish RA, Haulman NJ, Burns RM "Interaction of theophylline with erythromycin base in a patient with seizure activity." Pediatrics 72 (1983): 828-30. [PMID: 6646925]
120	Paulsen O, Hoglund P, Nilsson LG, Bengtsson HI "The interaction of erythromycin with theophylline." Eur J Clin Pharmacol 32 (1987): 493-8. [PMID: 3622597]
121	Peters DH, Friedel HA, McTavish D "Azithromycin: a review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy." Drugs 44 (1992): 750-99. [PMID: 1280567]
122	Pfeifer HJ, Greenblatt DJ, Friedman P "Effects of three antibiotics on theophylline kinetics." Clin Pharmacol Ther 26 (1979): 36-40. [PMID: 445960]
123	Pollak PT, Slayter KL "Reduced serum theophylline concentrations after discontinuation of azithromycin: evidence for an unusual interaction." Pharmacotherapy 17 (1997): 827-9. [PMID: 9250566]
124	Prince RA, Wing DS, Weinberger MM, et al "Effect of erythromycin on theophylline kinetics." J Allergy Clin Immunol 68 (1981): 427-31. [PMID: 7031111]
125	Principi N, Esposito S "Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric: Patients." Drug Safety 20 (1999): 25-41. [PMID: 9935275]
126	Reisz G, Pingleton SK, Melethil S, Ryan PB "The effect of erythromycin on theophylline pharmacokinetics in chronic bronchitis." Am Rev Respir Dis 127 (1983): 581-4. [PMID: 6846940]
127	Renton KW, Gray JD, Hung OR "Depression of theophylline elimination by erythromycin." Clin Pharmacol Ther 30 (1981): 422-6. [PMID: 7273607]
128	Richer C, Mathieu M, Bah H, Thuillez C, Duroux P, Giudicelli JF "Theophylline kinetics and ventilatory flow in bronchial asthma and chronic airflow obstruction: influence of erythromycin." Clin Pharmacol Ther 31 (1982): 579-86. [PMID: 7075107]
129	Tenenbein M "Theophylline toxicity due to drug interaction." J Emerg Med 7 (1989): 249-51. [PMID: 2745945]
130	von Rosenstiel NA, Adam D "Macrolide antibacterials. Drug interactions of clinical significance." Drug Saf 13 (1995): 105-22. [PMID: 7576262]
131	Wiggins J, Arbab O, Ayres JG, Skinner C "Elevated serum theophylline concentration following cessation of erythromycin treatment." Eur J Respir Dis 68 (1986): 298-300. [PMID: 3732425]
132	Zarowitz BJ, Szefler SJ, Lasezkay GM "Effect of erythromycin base on theophylline kinetics." Clin Pharmacol Ther 29 (1981): 601-5. [PMID: 7214790]
133	Bukowskyj M, Nakatsu K, Munt PW "Theophylline reassessed." Ann Intern Med 101 (1984): 63-73. [PMID: 6145380]
134	Dahlqvist R, Steiner E, Koike Y, von Bahr C, Lind M, Billing B "Induction of theophylline metabolism by pentobarbital." Ther Drug Monit 11 (1989): 408-10. [PMID: 2741188]
135	Landay RA, Gonzalez MA, Taylor JC "Effect of phenobarbital on theophylline disposition." J Allergy Clin Immunol 62 (1978): 27-9. [PMID: 659737]
136	Mitchell EA "Interaction between carbamazinepine and theophylline." N Z Med J 1 (1986): 69-70. [PMID: 3080715]
137	Rosenberry KR, Defusco CJ, Mansmann HC, McGeady SJ "Reduced theophylline half-life induced by carbamazepine therapy." J Pediatr 102 (1983): 472-4. [PMID: 6827425]
138	Anderson JR, Poklis A, Slavin RG "A fatal case of theophylline intoxication." Arch Intern Med 143 (1983): 559-60. [PMID: 6830388]
139	Bachmann KA, Sullivan TJ, Jauregui L, Reese J, Miller K, Levine L "Drug interactions of h-2-receptor antagonists." Scand J Gastroenterol 29 (1994): 14-9. [PMID: 7863246]
140	Bauman JH, Kimelblatt BJ, Caraccio TR, Silverman HM, Simon GI, Beck GJ "Cimetidine-theophylline interaction: report of four patients." Ann Allergy 48 (1982): 100-2. [PMID: 6121526]
141	Boehning W "Effect of cimetidine and ranitidine on plasma theophylline in patients with chronic obstructive airways disease treated with theophylline and corticosteroids." Eur J Clin Pharmacol 38 (1990): 43-5. [PMID: 2328746]
142	Campbell MA, Plachetka JR, Jackson JE, Moon JF, Finley PR "Cimetidine decreases theophylline clearance." Ann Intern Med 95 (1981): 68-9. [PMID: 7247131]
143	Dal Negro R, Pomari C, Turco P "Famotidine and theophylline pharmacokinetics. An unexpected cimetidine-like interaction in patients with chronic obstructive pulmonary disease." Clin Pharmacokinet 24 (1993): 255-8. [PMID: 8462230]
144	Fenje PC, Isles AF, Baltodano A, MacLeod SM, Soldin S "Interaction of cimetidine and theophylline in two infants." Can Med Assoc J 126 (1982): 1178. [PMID: 7074441]
145	Fernandes E, Melewicz FM "Ranitidine and theophylline." Ann Intern Med 100 (1984): 459. [PMID: 6320702]
146	Hegman GW, Gilbert RP "Ranitidine-theophylline interaction--fact or fiction?" Ann Pharmacother 25 (1991): 21-5. [PMID: 2008782]
147	Hsu K, Garton A, Sproule BJ, Tam YK, Leggatt D, Herbert FA "The influence of orally administered cimetidine and theophylline on the elimination of each drug in patients with chronic airways obstruction." Am Rev Respir Dis 130 (1984): 740-3. [PMID: 6497156]
148	Jackson JE, Powell JR, Wandell M, Bentley J, Dorr R "Cimetidine decreases theophylline clearance." Am Rev Respir Dis 123 (1981): 615-7. [PMID: 7023306]
149	Kehoe WA, Sands CD, Long LF, et al "Effect of ranitidine on theophylline metabolism in healthy Koreans living in China." Ann Pharmacother 30 (1996): 133-7. [PMID: 8835044]
150	Kelly HW "Lack of evidence for reduction of theophylline clearance by ranitidine." Am J Med 86 (1989): 629-32. [PMID: 2712078]
151	Kelly HW, Powell JR, Donohue JF "Ranitidine at very large doses does not inhibit theophylline elimination." Clin Pharmacol Ther 39 (1986): 577-81. [PMID: 3698466]
152	Lin JH, Chremos AN, Chiou R, Yeh KC, Williams R "Comparative effect of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteers." Br J Clin Pharmacol 24 (1987): 669-72. [PMID: 2893637]
153	Lofgren RP, Gilbertson RA "Cimetidine and theophylline." Ann Intern Med 96 (1982): 378. [PMID: 6800293]
154	Ohashi K, Sakamoto K, Sudo T, Tateishi T, Fujimura A, Shiga T, Ebihara A "Effects of diltiazem and cimetidine on theophylline oxidative metabolism." J Clin Pharmacol 33 (1993): 1233-7. [PMID: 8126258]
155	Powell JR, Rogers JF, Wargin WA, Cross RE, Eshelman FN "Inhibition of theophylline clearance by cimetidine but not ranitidine." Arch Intern Med 144 (1984): 484-6. [PMID: 6322709]
156	Pride M, Deamer RL "Over-the-counter cimetidine and theophylline interaction." Am Fam Physician 52 (1995): 2180. [PMID: 7484712]
157	Reitberg DP, Bernhard H, Schentag JJ "Alteration of theophylline clearance and half-life by cimetidine in normal volunteers." Ann Intern Med 95 (1981): 582-5. [PMID: 7294546]
158	Roy AK, Cuda MP, Levine RA "Induction of theophylline toxicity and inhibition of clearance rates by ranitidine." Am J Med 85 (1988): 525-7. [PMID: 3177399]
159	Schwartz JI, Bachmann KA, Bond LW, Mahajan VK "Impact of cimetidine on the pharmacokinetics of the theophylline." Clin Pharm 1 (1982): 534-8. [PMID: 7185539]
160	Skinner MH, Lenert L, Blaschke TF "Theophylline toxicity subsequent to ranitidine administration: a possible drug-drug interaction." Am J Med 86 (1989): 129-32. [PMID: 2910084]
161	Verdiani P, Di Carlo S, Baronti A "Famotidine effects on theophylline pharmacokinetics in subjects affected by COPD: comparison with cimetidine and placebo." Chest 94 (1988): 807-10. [PMID: 3168576]
162	Weinberger MM, Smith G, Milavetz G, Hendeles L "Decreased clearance of theophylline due to cimetidine ." N Engl J Med 304 (1981): 672. [PMID: 7453751]
163	Bachmann K, Sullivan TJ, Reese JH, Jauregui L, Miller K, Scott M, Yeh KC, Stepanavage M, King JD, Schwartz J "Controlled study of the putative interaction between famotidine and theophylline in patients with chronic obstructive pulmonary disease." J Clin Pharmacol 35 (1995): 529-35. [PMID: 7657856]
164	Azar I, Kumar D, Betcher AM "Resistance to pancuronium in an asthmatic patient treated with aminophylline and steroids." Can Anaesth Soc J 29 (1982): 280-2
165	Daller JA, Erstad B, Rosado L, Otto C, Putnam CW "Aminophylline antagonizes the neuromuscular blockade of pancuronium but not vecuronium." Crit Care Med 19 (1991): 983-5
166	Doll DC, Rosenberg H "Antagonism of neuromuscular blockage by theophylline." Anesth Analg 58 (1979): 139-40
167	Product Information. Welchol (colesevelam) Daiichi Sankyo, Inc., Parsippany, NJ.
168	Gotz VP, Ryerson GG "Evaluation of tetracycline on theophylline disposition in patients with chronic obstructive airways disease." Drug Intell Clin Pharm 20 (1986): 694-6. [PMID: 3757782]
169	McCormack JP, Reid SE, Lawson LM "Theophylline toxicity induced by tetracycline." Clin Pharm 9 (1990): 546-9. [PMID: 2376112]
170	Abernethy DR, Egan JM, Dickinson TH, Carrum G "Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans." J Pharmacol Exp Ther 244 (1988): 994-9. [PMID: 3252045]
171	Christopher MA, Harman E, Hendeles L "Clinical relevance of the interaction of theophylline with diltiazem or nifedipine." Chest 95 (1989): 309-13. [PMID: 2914480]
172	Nafziger AN, May JJ, Bertino JS Jr "Inhibition of theophylline elimination by diltiazem therapy." J Clin Pharmacol 27 (1987): 862-5. [PMID: 3429693]
173	Smith SR, Haffner CA, Kendall MJ "The influence of nifedipine and diltiazem on serum theophylline concentration-time profiles." J Clin Pharm Ther 14 (1989): 403-8. [PMID: 2584285]
174	Soto J, Sacristan JA, Alsar MJ "Diltiazem treatment impairs theophylline elimination in patients with bronchospastic airway disease." Ther Drug Monit 16 (1994): 49-52. [PMID: 8160255]
175	Loi CM, Day JD, Jue SG, et al "Dose-dependent inhibition of theophylline metabolism by disulfiram in recovering alcoholics." Clin Pharmacol Ther 45 (1989): 476-86. [PMID: 2721103]
176	Gardner MJ, Tornatore KM, Jusko WJ, Kanarkowski R "Effects of tobacco smoking and oral contraceptive use on theophylline disposition." Br J Clin Pharmacol 16 (1983): 271-80. [PMID: 6626419]
177	Roberts RK, Grice J, McGuffie, Heilbronn L "Oral contraceptive steroids impair the elimination of theophylline." J Lab Clin Med 101 (1983): 821-25. [PMID: 6854122]
178	Tornatore KM, Kanarkowski R, McCarthy TL, et al "Effect of chronic oral contraceptive steroids on theophylline disposition." Eur J Clin Pharmacol 23 (1982): 129-34. [PMID: 7140802]
179	Miller M, Cosgriff J, Kwong T, Morken DA "Influence of phenytoin on theophylline clearance." Clin Pharmacol Ther 35 (1984): 666-9. [PMID: 6713777]
180	Sklar SJ, Wagner "Enhanced theophylline clearance secondary to phenytoin therapy." Drug Intell Clin Pharm 19 (1985): 34-6. [PMID: 3967572]
181	Jonkman JH, Nicholson KG, Farrow PR, et al "Effects of alpha-interferon on theophylline pharmacokinetics and metabolism." Br J Clin Pharmacol 27 (1989): 795-802. [PMID: 2757895]
182	Kramer P, Tsuru M, Cook CE, et al "Effect of influenza vaccine on warfarin anticoagulation." Clin Pharmacol Ther 35 (1984): 416-8. [PMID: 6697649]
183	Okuno H, Takasu M, Kano H, Seki T, Shiozaki Y, Inoue K "Depression of drug-metabolizing activity in the human liver by interferon-beta." Hepatology 17 (1993): 65-9. [PMID: 8423043]
184	Product Information. Intron A (interferon alfa-2b). Schering Laboratories, Kenilworth, NJ.
185	Sakai H, Okamoto T, Kikkawa Y "Suppression of hepatic drug metabolism by the interferon inducer polyriboinosinic acid:polyribocitidylic acid." J Pharmacol Exp Ther 263 (1992): 381-6. [PMID: 1403800]
186	Williams SJ, Baird-Lambert JA, Farrell GC "Inhibition of theophylline metabolism by interferon." Lancet 10/24/87 (1987): 939-41. [PMID: 2444839]
187	Dal Negro R, Turco P, Trevisan F, De Conti F "Rifampicin-isoniazid and delayed elimination of theophylline: a case report." Int J Clin Pharmacol Res 8 (1988): 275-7. [PMID: 3182118]
188	Hoglund P, Nilsson LG, Paulson O "Interaction between isoniazid and theophylline." Eur J Respir Dis 70 (1987): 110-6. [PMID: 3817069]
189	Torrent J, Izquierdo I, Cabezas R, Jane F "Theophylline-isoniazid interaction." DICP 23 (1989): 143-5. [PMID: 2728504]
190	Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm 66 (2009): 1438-67. [PMID: 19667002]
191	Vozeh S, Otten M, Staub JJ, Follath F "Influence of thyroid function on theophylline kinetics." Clin Pharmacol Ther 36 (1984): 634-40
192	Bauman JH, Teichman S, Wible DA "Increased theophylline clearance in a patient with hyperthyroidism." Ann Allergy 52 (1984): 94-6
193	Matsuoka LY "Convulsions following application of gamma benzene hexachloride." J Am Acad Dermatol 5 (1981): 98-9. [PMID: 6168673]
194	Cox R, Krupnick J, Bush N, Houpt A "Seizures caused by concomitant use of lindane and dextroamphetamine in a child with attention deficit hyperactivity disorder." J Miss State Med Assoc 41 (2000): 690-2. [PMID: 10974795]
195	Product Information. Kwell (lindane). Reed and Carnrick, Jersey City, NJ.
196	Davis RL, Kelly HW, Quenzer RW, Standefer J, Steinberg B, Gallegos J "Effect of norfloxacin on theophyllin metabolism." Antimicrob Agents Chemother 33 (1989): 212-4. [PMID: 2719466]
197	Ball P "Ciprofloxacin: an overview of adverse experiences." J Antimicrob Chemother 18 (1986): 187-93. [PMID: 3542945]
198	Bowles SK, Popovski Z, Rybak MJ, Beckman HB, Edwards DJ "Effect of norfloxacin on theophylline pharmacokinetics at steady state." Antimicrob Agents Chemother 32 (1988): 510-12. [PMID: 3377462]
199	Covelli HD, Knodel AR, Heppner BT "Predisposing factors to apparent theophylline-induced seizures." Ann Allergy 54 (1985): 411-5. [PMID: 3994071]
200	Green L, Clark J "Fluoroquinolones and theophylline toxicity: norfloxacin." JAMA 262 (1989): 2383. [PMID: 2795820]
201	Gregoire SL, Grasela TH Jr, Freer JP, Tack KJ, Schentag JJ "Inhibition of theophylline clearance by coadministered ofloxacin without alteraction of theophylline effects." Antimicrob Agents Chemother 31 (1987): 375-8. [PMID: 3472488]
202	Ho G, Tierney MG, Dales RE "Evaluation of the effect of norfloxacin on the pharmacokinetics of theophylline." Clin Pharmacol Ther 44 (1988): 35-8. [PMID: 3391003]
203	Hooper DC, Wolfson JS "The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans." Antimicrob Agents Chemother 28 (1985): 716-21. [PMID: 2936302]
204	Product Information. Cinobac (cinoxacin). Oclassen Pharmaceuticals Inc, San Rafael, CA.
205	Sano M, Yamamoto I, Ueda J, Yoskikawa E, Yamashina H, Goto M "Comparative pharmacokinetics of theophylline following two fluoroquinolones co-administration." Eur J Clin Pharmacol 32 (1987): 431-2. [PMID: 3475207]
206	Bonuccelli U, Piccini P, Del Dotto P, Pavese N, D'Antonio P, Muratorio A "Apomorphine test in de novo Parkinson's disease." Funct Neurol 7 (1992): 295-8. [PMID: 1427361]
207	Chernish SM, Wolen RL, Rodda BE "Adsorption of propoxyphene hydrochloride by activated charcoal." Clin Toxicol 5 (1972): 317-29. [PMID: 5073815]
208	Decker WJ, Shpall RA, Corby DG "Inhibition of aspirin absorption by activated charcoal and apomorphine." Clin Pharmacol Ther 10 (1969): 710-3. [PMID: 5808464]
209	Dolgin JG, Nix DE, Sanchez J, Watson WA "Pharmacokinetic simulation of the effect of multiple-dose activated charcoal in phenytoin poisoning: report of two pediatric cases." DICP 25 (1991): 646-9. [PMID: 1877275]
210	Farrar HC, Herold DA, Reed MD "Acute valproic acid intoxication: enhanced drug clearance with oral-activated charcoal." Crit Care Med 21 (1993): 299-301. [PMID: 8428486]
211	Gadgil SD, Damle SR, Advani SH, Vaidya AB "Effect of activated charcoal on the pharmacokinetics of high-dose methotrexate." Cancer Treat Rep 66 (1982): 1169-71. [PMID: 7083219]
212	Glab WN, Corby DG, Decker WJ, Coldiron VR "Decreased absorption of propoxyphene by activated charcoal." J Toxicol Clin Toxicol 19 (1982): 129-38. [PMID: 6125599]
213	Herrington AM, Clifton GD "Toxicology and management of acute drug ingestions in adults." Pharmacotherapy 15 (1995): 182-200. [PMID: 7624266]
214	Howard CE, Roberts RS, Ely DS, Moye RA "Use of multiple-dose activated charcoal in phenytoin toxicity." Ann Pharmacother 28 (1994): 201-3. [PMID: 8173135]
215	Ilkhanipour K, Yealy DM, Krenzelok EP "Activated charcoal surface area and its role in multiple-dose charcoal therapy." Am J Emerg Med 11 (1993): 583-5. [PMID: 8240556]
216	Karkkainen S, Neuvonen PJ "Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics." Int J Clin Pharmacol Ther Toxicol 23 (1985): 219-25. [PMID: 2987139]
217	Kivisto KT, Neuvonen PJ "The effect of cholestyramine and activated charcoal on glipizide absorption." Br J Clin Pharmacol 30 (1990): 733-6. [PMID: 2271372]
218	Knadler MP, Bergstrom RF, Callaghan JT, Obermeyer BD, Rubin A "Absorption studies of the H2-blocker nizatidine." Clin Pharmacol Ther 42 (1987): 514-20. [PMID: 2890459]
219	Naveau S, Bonhomme L, Preaux N, Chaput JC "A pure charcoal suspension for colonoscopic tattoo." Gastrointest Endosc 37 (1991): 624-5. [PMID: 1756921]
220	Neuvonen PJ "Clinical pharmacokinetics of oral activated charcoal in acute intoxications." Clin Pharmacokinet 7 (1982): 465-89. [PMID: 6761032]
221	Orisakwe OE "Activated charcoal: is failure to use it negligence or ignorance?" South Med J 87 (1994): 165-8. [PMID: 8115876]
222	Park GD, Spector R, Goldberg MJ, Johnson GF "Expanded role of charcoal therapy in the poisoned and overdosed patient." Arch Intern Med 146 (1986): 969-73. [PMID: 3516107]
223	Product Information. Trileptal (oxcarbazepine) Novartis Pharmaceuticals, East Hanover, NJ.
224	Reed MD "Oral activated charcoal therapy." Am J Emerg Med 6 (1988): 318. [PMID: 3370115]
225	Rowden AM, Spoor JE, Bertino JS, Jr "The effect of activated charcoal on phenytoin pharmacokinetics." Ann Emerg Med 19 (1990): 1144-7. [PMID: 2221521]
226	Saetta JP "Gastric decontaminating procedures: is it time to call a stop?" J R Soc Med 86 (1993): 396-9. [PMID: 8371247]
227	Scheufler E, Bos I "Influence of peroral charcoal on pharmacokinetics and intestinal toxicity of intravenously given methotrexate." Arch Int Pharmacodyn Ther 261 (1983): 180-5. [PMID: 6838279]
228	Wakabayashi Y, Maruyama S, Hachimura K, Ohwada T "Activated charcoal interrupts enteroenteric circulation of phenobarbital." J Toxicol Clin Toxicol 32 (1994): 419-24. [PMID: 8057401]
229	Watson WA "Factors influencing the clinical efficacy of activated charcoal." Drug Intell Clin Pharm 21 (1987): 160-6. [PMID: 3549212]
230	Wing LM, Miners JO, Birkett DJ, et al "Lidocaine disposition: sex differences and effects of cimetidine." Clin Pharmacol Ther 35 (1984): 695-701. [PMID: 6713782]
231	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
232	Product Information. Firdapse (amifampridine). Catalyst Pharmaceuticals, Inc., Coral Gables, FL.
233	Product Information. Blincyto (blinatumomab). Amgen USA, Thousand Oaks, CA.
234	Jusko WJ, Schentag JJ, Clark JH, Gardner M, Yurchak AM "Enhanced biotransformation of theophylline in marijuana and tobacco smokers." Clin Pharmacol Ther 24 (1978): 405-10. [PMID: 688731]
235	Product Information. Dronabinol (dronabinol). Watson Pharmaceuticals, Parsippany, NJ.
236	Product Information. Uloric (febuxostat). Takeda Pharmaceuticals America, Lincolnshire, IL.
237	Crowley JJ, Cusack BJ, Jue SG, et al "Cigarette smoking and theophylline metabolism: effects of phenytoin." Clin Pharmacol Ther 42 (1987): 334-40. [PMID: 3621789]
238	Kajiyama Y, Fujii K, Takeuchi H, Manabe Y "Ginkgo seed poisoning." Pediatrics 109 (2002): 325-7. [PMID: 11826216]
239	Granger AS "Ginkgo biloba precipitating epileptic seizures." Age Ageing 30 (2001): 523-5. [PMID: 11742783]
240	Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
241	Spinella M "Herbal medicines and epilepsy: the potential for benefit and adverse effects." Epilepsy Behav 2 (2001): 524-32. [PMID: 12609386]
242	Gregory PJ "Seizure associated with Ginkgo biloba?." Ann Intern Med 134 (2001): 344. [PMID: 11182853]
243	Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE "Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder." Epilepsia 47 (2006): 323-9. [PMID: 16499756]
244	Miwa H, Iijima M, Tanaka S, Mizuno Y "Generalized convulsions after consuming a large amount of Gingko nuts." Epilepsia 42 (2001): 280-1. [PMID: 11240603]
245	Kupiec T, Raj V "Fatal seizures due to potential herb-drug interactions with Ginkgo biloba." J Anal Toxicol 29 (2005): 755-8. [PMID: 16419414]
246	Product Information. Myalept (metreleptin). Bristol-Myers Squibb, Princeton, NJ.
247	Product Information. Ocaliva (obeticholic acid). Intercept Pharmaceuticals, Inc., New York, NY.
248	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
249	Salik JM, Kurtin P "Severe hyponatremia after colonoscopy preparation in a patient with the acquired immune deficiency syndrome." Am J Gastroenterol 80 (1985): 177-9. [PMID: 2983533]
250	Fugh-Berman A "Herb-drug interactions." Lancet 355 (2000): 134-8. [PMID: 10675182]
251	Izzo AA, Ernst E "Interactions between herbal medicines and prescribed drugs: a systematic review." Drugs 61 (2001): 2163-75. [PMID: 11772128]
252	Nebel A, Schneider BJ, Baker RK, Kroll DJ "Potential metabolic interaction between St. John's wort and theophylline." Ann Pharmacother 33 (1999): 502. [PMID: 10332544]
253	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
254	Strayhorn VA, Baciewicz AM, Self TH "Update on rifampin drug interactions, III." Arch Intern Med 157 (1997): 2453-8. [PMID: 9385296]
255	Venkatesan K "Pharmacokinetic drug interactions with rifampicin." Clin Pharmacokinet 22 (1992): 47-65. [PMID: 1559307]
256	Hsu A, Granneman GR, Bertz RJ. Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents [published correction appears in Clin Pharmacokinet 1998 Dec;35(6):473]. Clin Pharmacokinet. 1998;35(4):275-291. [PMID: 9812178]
257	Product Information. Norvir (ritonavir). Abbott Pharmaceutical, Abbott Park, IL.
258	Lew G, Murray WE, Lane JR, Haeger E "Theophylline-thiabendazole drug interaction." Clin Pharm 8 (1989): 225-7. [PMID: 2706897]
259	Schneider D, Gannon R, Sweeney K, Shore E "Theophylline and antiparasitic drug interactions: a case report and study of the influence of thiabendazole and mebendazole on theophylline pharmacokinetics in adult." Chest 97 (1990): 84-7. [PMID: 2295264]
260	Sugar AM, Kearns PJ, Haulk AA, Rushing JL "Possible thiabendazole-induced theophylline toxicity." Am Rev Respir Dis 122 (1980): 501-3. [PMID: 7416626]
261	Fuhr U, Woodcock BG, Siewart M "Verapamil and drug metabolism by the cytochrome p450 isoform CYP1A2." Eur J Clin Pharmacol 42 (1992): 463-4. [PMID: 1516612]
262	Gin AS, Stringer KA, Welage LS, et al "The efect of verapamil on the pharmacokinetic disposition of theophylline in cigarette smokers." J Clin Pharmacol 29 (1989): 728-32. [PMID: 2778093]
263	McTavish D, Sorkin EM "Verapamil: an updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension." Drugs 38 (1989): 19-76. [PMID: 2670511]
264	Nielsen-Kudsk JE, Buhl JS, Johannessen AC "Verapamil-induced inhibition of theophylline elimination in healthy humans." Pharmacol Toxicol 66 (1990): 101-3. [PMID: 2315261]
265	Stringer KA, Mallet J, Clarke M, Lindenfield JA "The effect of three different oral doses of verapamil on the disposition of theophylline." Eur J Clin Pharmacol 43 (1992): 35-8. [PMID: 1505606]
266	Taniguchi A, Ohe T, Shimorura K "Theophylline-induced ventricular tachycardia in a patient with chronic lung disease: sensitivity to verapamil." Chest 96 (1989): 958-9. [PMID: 2791703]
267	Granneman GR, Braeckman RA, Locke CS, Cavanaugh JH, Dube LM, Awni WM "Effect of zileuton on theophylline pharmacokinetics." Clin Pharmacokinet 29(suppl 2 (1995): 77-83. [PMID: 8620674]
268	Lau R "Drug interactions with zileuton." Lancet 349 (1997): 1479-80. [PMID: 9164345]
269	Product Information. Zylo Filmtab (zileuton). Abbott Pharmaceutical, Abbott Park, IL.
270	Gallen JS "Aminophylline reversal of midazolam sedation." Anesth Analg 69 (1989): 268
271	Bonfiglio MF, Dasta JF "Clinical significance of the benzodiazepine-theophylline interaction." Pharmacotherapy 11 (1991): 85-7
272	Tuncok Y, Akpinar O, Guven H, Akkoclu A "The effects of theophylline on serum alprazolam levels." Int J Clin Pharmacol Ther 32 (1994): 642-5
273	Bratel T, Billing B, Dahlqvist R "Felodipine reduces the absorption of theophylline in man." Eur J Clin Pharmacol 36 (1989): 481-5. [PMID: 2753066]
274	Brown MW, Maldonado AL, Meredith CG, Speeg KV "Effect of ketoconazole on hepatic oxidative drug metabolism." Clin Pharmacol Ther 37 (1985): 290-7. [PMID: 3971653]
275	Heusner JJ, Dukes GE, Rollins DE, et al "Effect of chronically administered ketoconazole on the elimination of theophylline in man." Drug Intell Clin Pharm 21 (1987): 514-7. [PMID: 3608798]
276	Product Information. CellCept (mycophenolate mofetil). Roche Laboratories, Nutley, NJ.
277	Jonkman JH, Sollie FA, Sauter R, Steinijans VW "The influence of caffeine on the steady-state pharmacokinetics of theophylline." Clin Pharmacol Ther 49 (1991): 248-55. [PMID: 2007319]
278	Sato J, Nakata H, Owada E, Kikuta T, Umetsu M, Ito K "Influence of usual intake of dietary caffeine on single-dose kinetics of theophylline in healthy human subjects." Eur J Clin Pharmacol 44 (1993): 295-8. [PMID: 8491248]
279	Taylor BL, Collins C "Aminophylline and propofol: apparent antagonism." Anaesthesia 43 (1988): 508

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence